TARA DEGNAN: Open Payments
NPI 1023665460 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,195 in 95 payments from 17 companies in 2025. Trend: 2023 $1,130 · 2024 $1,518 · 2025 $2,195
Food & beverage: $2,150Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $585 |
| Novo Nordisk Inc | 21 | $485 |
| AstraZeneca Pharmaceuticals LP | 9 | $339 |
| Lilly USA, LLC | 8 | $178 |
| GlaxoSmithKline, LLC. | 6 | $136 |
| Exact Sciences Corporation | 3 | $82 |
| Astellas Pharma US Inc | 3 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Dexcom, Inc. | 3 | $54 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
Products named: QULIPTA, AIRSUPRA, Ozempic, MOUNJARO, VRAYLAR, Rybelsus, Cologuard Collection Kit, Wegovy.
Industry payments across PA — which companies pay providers there.
